Back to search

Article

Secondary bile acid lithocholic acid ameliorates colitis-like inflammation in a human intestine-on-chip system

2025-11-08

Abstract excerpt

Inflammatory bowel disease (IBD) is a multifactorial disease of the gastrointestinal tract without curative treatment. Previous studies highlighted that altered fecal bile acid levels correlate with intestinal microbiota composition changes and inflammation in IBD. Lithocholic acid (LCA) is a secondary bile acid (SBA) drastically reduced during active IBD but mediates beneficial effects at the mucosal intestinal b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e2cb51a2-78f6-51a9-80fc-7aa4c30ed31b
DOI
10.1101/2025.11.07.686950
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Secondary bile acid lithocholic acid ameliorates colitis-like inflammation in a human intestine-on-chip systemDOI 10.1101/2025.11.07.686950
Select a neighboring publication to make it the new centre.